Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Turnaround Potential
1286.0000 6.40 (0.50%)
NSE Mar 17, 2026 15:31 PM
Volume: 635.2K
 

1286.00
0.50%
Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. is trading above all available SMAs
More from Aurobindo Pharma Ltd.
Recommended